2012-10-10 01:13:50 - New Pharmaceuticals market report from Global Markets Direct: "ProtAffin Biotechnologie AG - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "ProtAffin Biotechnologie AG - Product Pipeline Review - 2012" provides data on the ProtAffin Biotechnologie AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, ProtAffin Biotechnologie AG's corporate website, SEC filings, investor presentations and featured press releases, both from ProtAffin Biotechnologie AG and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* ProtAffin Biotechnologie AG - Brief ProtAffin Biotechnologie AG overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline

of ProtAffin Biotechnologie AG human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of ProtAffin Biotechnologie AG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the ProtAffin Biotechnologie AG's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468590_protaffin_biotechnologie_ag_product_p ..


Reasons to buy

* Evaluate ProtAffin Biotechnologie AG's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of ProtAffin Biotechnologie AG in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the ProtAffin Biotechnologie AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with ProtAffin Biotechnologie AG.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of ProtAffin Biotechnologie AG and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
ProtAffin Biotechnologie AG Snapshot
ProtAffin Biotechnologie AG Overview
Key Information
Key Facts
ProtAffin Biotechnologie AG - Research and Development Overview
Key Therapeutic Areas
ProtAffin Biotechnologie AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
ProtAffin Biotechnologie AG - Pipeline Products Glance
ProtAffin Biotechnologie AG - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
ProtAffin Biotechnologie AG - Drug Profiles
Drug For Oncology 1
Product Description
Mechanism of Action
R&D Progress
Drug For Oncology 2
Product Description
Mechanism of Action
R&D Progress
MCP-1 Program
Product Description
Mechanism of Action
R&D Progress
PA-401
Product Description
Mechanism of Action
R&D Progress
SDF-1 Alpha Program
Product Description
Mechanism of Action
R&D Progress
ProtAffin Biotechnologie AG - Pipeline Analysis
ProtAffin Biotechnologie AG - Pipeline Products by Therapeutic Class
ProtAffin Biotechnologie AG - Recent Pipeline Updates
ProtAffin Biotechnologie AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
ProtAffin Biotechnologie AG, Recent Developments
ProtAffin Biotechnologie AG- Press Release
Jun 27, 2012: ProtAffin Starts Phase I Study For PA401 In Inflammatory Lung Disease
May 22, 2012: ProtAffin Presents New Preclinical Data Of PA401 At American Thoracic Society Conference
Financial Deals Landscape
ProtAffin Biotechnologie AG, Deals Summary
ProtAffin Biotechnologie AG, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
ProtAffin Biotechnologie Secures $18.4 Million In Series B Financing
ProtAffin Biotechnologie Secures $1.99 Million In Final Tranche Of Series A Financing
ProtAffin Biotechnologie Secures $3.6 Million In Series A Financing
ProtAffin Biotechnologie Secures $1.54 Million In Seed Financing
Partnerships
ProtAffin Biotechnologie Enters Into An Agreement With Intercell
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
ProtAffin Biotechnologie AG, Key Information
ProtAffin Biotechnologie AG, Key Facts
ProtAffin Biotechnologie AG - Pipeline by Indication, 2012
ProtAffin Biotechnologie AG - Pipeline by Stage of Development, 2012
ProtAffin Biotechnologie AG - Monotherapy Products in Pipeline, 2012
ProtAffin Biotechnologie AG - Pre-Clinical, 2012
ProtAffin Biotechnologie AG - Discovery, 2012
ProtAffin Biotechnologie AG - Pipeline By Therapeutic Class, 2012
ProtAffin Biotechnologie AG - Recent Pipeline Updates, 2012
ProtAffin Biotechnologie AG, Other Locations
ProtAffin Biotechnologie AG, Deals Summary
ProtAffin Biotechnologie Secures $18.4 Million In Series B Financing
ProtAffin Biotechnologie Secures $1.99 Million In Final Tranche Of Series A Financing
ProtAffin Biotechnologie Secures $3.6 Million In Series A Financing
ProtAffin Biotechnologie Secures $1.54 Million In Seed Financing

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468590&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.